Technology and Transparency Are Watchwords For This Life-Science Company - #1113
Never miss another interview! Join Devin here: http://bit.ly/joindevin. Reginald Swift, CEO and founder of Rubix LS, is working to accelerate cures for rare diseases by utilizing new technology and increasing transparency between patients and companies. Interview with Reginald Swift, the CEO of Rubix LS. The following is the pre-interview with Reginald Swift. Be sure to watch the recorded interview above. For-profit/Nonprofit: For-profit Revenue model: Currently providing consultation services to commercial entities as well as providing innovation towards the federal government via grants and contracts. Scale: Our devices are currently in clinical trials, but our commercial entity has reached a network of 60 subject matter experts in a number of regions that have supported the industry through various capacities. Click the following link to learn my insider secrets to media publicity for social impact: http://bit.ly/75offmedia.